Back to top

Ambry Genetics and Invicro Announce Partnership to Provide Enhanced Capabilities with Advanced Genomics Services to Enable Precision Medicine

February 6, 2018
No votes yet


Ambry Genetics Corporation (Ambry), leaders in genetic testing, announced today they will partner with Invicro, a leading provider of imaging services and software for research and drug development, to provide customized genomics and imaging services for the pharmaceutical and biotechnology industry, with a specialized focus on oncology and neurodegenerative diseases.

Both Invicro and Ambry Genetics were acquired by Konica Minolta in 2017 as a part of Konica Minolta's expansion into the clinical healthcare space.